Enterprise Value Chart

View Enterprise Value for ISPC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Enterprise Value Data

View and export this data back to 2021. Start Trial.
Date Value
September 11, 2026 -1.936M
September 10, 2026 -1.890M
September 09, 2026 -1.814M
September 08, 2026 -1.753M
September 04, 2026 -1.829M
September 03, 2026 -1.829M
September 02, 2026 -1.905M
September 01, 2026 -1.890M
August 31, 2026 -1.829M
August 28, 2026 -1.829M
August 27, 2026 -1.738M
August 26, 2026 -1.677M
August 25, 2026 -1.738M
August 24, 2026 -1.783M
August 21, 2026 -1.601M
August 20, 2026 -0.7177M
August 19, 2026 -0.5502M
August 18, 2026 -0.6111M
August 17, 2026 -0.9003M
August 14, 2026 -0.7481M
August 13, 2026 -0.672M
August 12, 2026 -0.7177M
August 11, 2026 -0.7024M
August 10, 2026 -0.7633M
August 07, 2026 -0.7938M
Date Value
August 06, 2026 -0.8242M
August 05, 2026 -1.250M
August 04, 2026 -0.9003M
August 03, 2026 -1.114M
July 31, 2026 -1.296M
July 30, 2026 -1.388M
July 29, 2026 -1.281M
July 28, 2026 -1.296M
July 27, 2026 -1.114M
July 24, 2026 -1.174M
July 23, 2026 -0.7785M
July 22, 2026 -0.7481M
July 21, 2026 -0.7329M
July 20, 2026 -0.6415M
July 17, 2026 -0.9765M
July 16, 2026 -0.809M
July 15, 2026 -0.7785M
July 14, 2026 -0.535M
July 13, 2026 -0.6111M
July 10, 2026 -0.3675M
July 09, 2026 -0.3066M
July 08, 2026 -0.6872M
July 07, 2026 -0.5197M
July 06, 2026 -0.2609M
July 02, 2026 -0.1544M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
LataMed AI Corp. 69.14M
SCWorx Corp. -0.9956M
Health Catalyst, Inc. 193.36M
GoodRx Holdings, Inc. 1.396B
Claritev Corp. 5.280B